on VALBIOTIS (EPA:ALVAL)
Valbiotis Launches Campaign to Tackle Cardiometabolic Risks in Women
Valbiotis, a French laboratory dedicated to cardiometabolic health, has initiated the "Cœur en Jeu" campaign to enhance awareness of cardiometabolic risks in women. The campaign, starting on March 10, 2026, is backed by the Agir pour le Cœur des Femmes Foundation, addressing the major public health issue of cardiovascular diseases, which notably impact women, especially during menopause.
The focus of the campaign is on lifestyle-related risk factors such as poor diet, stress, sedentary habits, and smoking, which are increasingly prevalent. The initiative highlights that 80% of cardiometabolic conditions can be prevented with proper lifestyle changes.
The campaign employs various strategies, including talks by healthcare professionals, educational tools, and testimonials, aiming to inform and empower women to take control of their health. Valbiotis stresses the importance of early recognition of warning signs and promotes a practical and positive approach to reducing these risks.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALBIOTIS news